Bank Of America Corp Fusion Pharmaceuticals Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.9 - $21.32 $553,987 - $1.5 Million	70,125 Added 5114.88%	71,496 $1.52 Million
Q4 2023 Feb 14, 2024	SELL	$2.48 - $9.65 $2,365 - $9,206	-954 Reduced 41.03%	1,371 $13,000
Q2 2023 Aug 14, 2023	BUY	$3.47 - $5.33 $8,067 - $12,392	2,325 New	2,325 $10,000
Q4 2021 Feb 08, 2022	SELL	$4.17 - $7.78 $5,842 - $10,899	-1,401 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $7,234 - $8,694	-924 Reduced 39.74%	1,401 $11,000
Q2 2021 Sep 13, 2021	BUY	$7.97 - $10.66 $18,530 - $24,784	2,325 New	2,325 $18,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.